1. Bayer to buy AskBio for $2B in bid to become gene therapy player — Novartis' most advanced kidney compound shows promise in C3G — JNJ and AZ COVID vaccine trials resuming — See more on our front page news Stay updated with the latest pharma-related coronavirus news on our new page
    Dismiss Notice
  2. Please take our quick survey on how COVID-19 is impacting your job It will only take a minute or two to respond. The survey is confidential, and does not require registration. Thank you in advance for your participation. We will provide regular updates on results as responses accumulate.
    Dismiss Notice

Infographic: Abbott Laboratories (ABT) Q1 2020 earnings

Discussion in 'Abbott' started by anonymous, Apr 16, 2020 at 8:27 AM.

  1. anonymous

    anonymous Guest

    Abbott Laboratories (ABT) reported its financial results for the quarter ended March 31, 2020 today.

    The company reported a 16% drop in earnings for the first quarter of 2020 due to tax expense despite a 2.5% increase in the top-line. Abbott is suspending its previously announced annual guidance for 2020 due to uncertainties regarding the duration and impact of the coronavirus (COVID-19) pandemic.

    Abbott launched three critical new tests for COVID-19, two molecular tests and one serology blood test for the detection of the antibody. While molecular testing detects whether someone has the virus, antibody tests determine if someone was previously infected.

    Take a look at the infographic here